Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FOXN3 antisense RNA 2 (FOXN3-AS2)
- Target
- FOXN3-AS2
- Molecular classification
- Other (long non-coding RNA)
01
Overview
FOXN3 antisense RNA 2 (FOXN3-AS2) is an uncharacterized long non-coding RNA (lncRNA) that is not a canonical protein-coding gene. It is transcribed antisense to the FOXN3 gene and is catalogued with Entrez Gene ID 29018. Its function as a biological target or receptor has not been well established in the current scientific literature, and its biological roles, involvement in disease, and potential as a therapeutic target remain undefined in primary sources. Most available references indicate its transcript nature, with expression described in tissues including excitatory neuronal cells. There is currently no evidence that FOXN3-AS2 serves as a therapeutic target, biomarker, or that it interacts with drugs. It should not be confused with the protein-coding gene FOXN3 (which is a transcription factor involved in tumor suppression, cell cycle regulation, and metabolic control), as their functions do not overlap based on current annotations.
- Other names
- PRO1768CTD-2303B20.1FOXN3 antisense RNA 2 (non-protein coding)
Beyond the preview
Go deeper on FOXN3 antisense RNA 2 (FOXN3-AS2).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on FOXN3 antisense RNA 2 (FOXN3-AS2).